Growth Metrics

Merck (MRK) Receivables - Net (2016 - 2026)

Merck has reported Receivables - Net over the past 18 years, most recently at $12.2 billion for Q1 2026.

  • Quarterly Receivables - Net rose 13.16% to $12.2 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $12.2 billion through Mar 2026, up 13.16% year-over-year, with the annual reading at $11.8 billion for FY2025, 14.57% up from the prior year.
  • Receivables - Net was $12.2 billion for Q1 2026 at Merck, up from $11.8 billion in the prior quarter.
  • Over five years, Receivables - Net peaked at $12.2 billion in Q1 2026 and troughed at $51.0 million in Q2 2023.
  • The 5-year median for Receivables - Net is $10.4 billion (2023), against an average of $8.5 billion.
  • Year-over-year, Receivables - Net plummeted 99.47% in 2023 and then surged 22727.45% in 2024.
  • A 5-year view of Receivables - Net shows it stood at $9.5 billion in 2022, then grew by 9.51% to $10.3 billion in 2023, then decreased by 0.69% to $10.3 billion in 2024, then grew by 14.57% to $11.8 billion in 2025, then rose by 3.69% to $12.2 billion in 2026.
  • Per Business Quant, the three most recent readings for MRK's Receivables - Net are $12.2 billion (Q1 2026), $11.8 billion (Q4 2025), and $12.1 billion (Q3 2025).